Who have Calcifying fibrous pseudotumor when taking Nexplanon and Tacrolimus - from FDA reports


Summary

There is no Calcifying fibrous pseudotumor reported by people who take Nexplanon and Tacrolimus yet. This review analyzes which people have Calcifying fibrous pseudotumor with . It is created by eHealthMe based on reports from FDA, and is updated regularly.


Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.



On May, 25, 2018
No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You are not alone: Connect with people like you, or share your experience to help people like you.

Analysis tools (to study 685 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

Expand the study to include reports from both FDA and eHealthMe

Calcifying fibrous pseudotumor with Nexplanon and Tacrolimus from FDA and eHealthme reports

What would happen?

Predict new side effects and undetected conditions when you take and have Calcifying fibrous pseudotumor

You are not alone. Join our personalized support groups:

Drugs that are associated with Calcifying fibrous pseudotumor

Calcifying fibrous pseudotumor

Could your condition cause Calcifying fibrous pseudotumor

Calcifying fibrous pseudotumor

Can you answer these questions

More questions for: Nexplanon, Tacrolimus, Calcifying fibrous pseudotumor

You may be interested in these posts

More posts for: Nexplanon, Tacrolimus, Calcifying fibrous pseudotumor



Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.